business
COMPANY BENCHMARKING • UNITED STATES

Glaxosmithkline Plc - Company Profile

Access all 5,000+ company profiles through Benchmarking Pro, available to Membership Plus subscribers. Unlock interactive competitor comparison tools that show you how Glaxosmithkline Plc stacks up to the competition and put relevant competitor and industry information at your fingertips.


Glaxosmithkline Plc - Overview

Brands
Block Drug Copmany Inc, Corixa Corporation, GlaxoSmithKline, GlaxoSmithKline Capital Inc, GlaxoSmithKline Consumer Healthcare Holdings LLC, GlaxoSmithKline Holdings, GSK Consumer Health, GSK Equity Investments, Human Genome Sciences Inc, PF Consumer Healthcare, Stiefel Labratories, Tesaro, ViiV Healthcare Company
Description
Glaxosmithkline is a public company headquartered in United Kingdom with an estimated 90,096 employees. In the US, the company has a notable market share in at least four industries: Brand Name Pharmaceutical Manufacturing, Epilepsy Medication Manufacturing, Cold Sore Medication Manufacturing, Mouthwash Manufacturing and Mouthwash Manufacturing. Their largest market share is in the Cold Sore Medication Manufacturing industry, where they account for an estimated 27.6% of total industry revenue and are considered an All Star because they display stronger market share, profit and revenue growth compared to their peers.
Company Details

Registered Name: Glaxosmithkline Plc

Company Type: Other

Exchange: NYSE, OTC

Headquarters: 980 Great West Road Brentford Middlesex X0 TW8 9GS

Employees: 90096

Glaxosmithkline Plc - Operating Industries and Main Competitors

error_outline To view all of Glaxosmithkline Plc's operating industries and competitors, see purchase options.

Glaxosmithkline Plc - Products and Services

  • Mouthwash Manufacturing in the US

  • Of the 3 core revenue-generating products and services in the Mouthwash Manufacturing in the US industry, Glaxosmithkline Plc offers:
    • Antiseptic mouthwashes
error_outline To view Glaxosmithkline Plc's full products and services, see purchase options.

Glaxosmithkline Plc - Analyst Insights

GSK demerges with its consumer division Haleon

GSK has announced the creation of new company Haleon as a part of its proposed demerger with Consumer Healthcare. The demerger is expected to take place in mid-2022 and represents a major milestone in GSKs restructuring initiative undertaken 8 years ago. Haleon is being set up as a standalone company, created with the input and hands-on experience of GSK employees, healthcare practitioners, and consumers alike.

Balance Sheet|New Activity|Structural|M&A


In response to volatile demand in the wake of the first COVID-19 surge, the company undertook a comprehensive cost reduction program, aimed at shoring up labor and supply costs.

Lorem Ipsum text header Report Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas non leo lacinia, consectetur ipsum non, pretium augue. Vestibulum accumsan dignissim massa, eu scelerisque mi malesuada ut. Aliquam scelerisque facilisis nisl ac varius. Nunc luctus nunc vel eros iaculis, vitae tristique ante fringilla. Ut vitae vulputate est, vel lacinia nisi. Curabitur eget nulla vitae mi faucibus imperdiet. Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.

Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.

error_outline To view all analyst insights on Glaxosmithkline Plc, see purchase options.

Glaxosmithkline Plc - SWOT Analysis

Strengths and weaknesses take into account internal factors, and are based on Glaxosmithkline Plc's performance in comparison to its competitors. Opportunities and Threats focus on external influences, and are based on trends and demand in the Brand Name Pharmaceutical Manufacturing in the US, Epilepsy Medication Manufacturing in the US, and Mouthwash Manufacturing in the US industries.
Strengths
Days Receivables: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Annual Turnover: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Weaknesses
Credit Risk: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Revenue per Employee: $xx
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Opportunities
  • AAAAA
  • AAAAA
  • AAAAA
Threats
  • AAAAA
  • AAAAA
  • AAAAA

error_outline To view Glaxosmithkline Plc's full SWOT analysis, see purchase options.

GET INSTANT ACCESS WITH MEMBERSHIP PLUS

100% Money Back Guarantee Digicert Trusted

BENCHMARKING PRO

What's Inside
Benchmarking Pro?

Available with US Membership Plus packages, this suite of company and industry data:

Benchmarks companies against industry averages or like-sized segments, as well as close competitors
Identifies real-world strengths, opportunites, weaknesses and threats
Reveals growth opportunities or red flags in a business growth strategy

Included in Report

  • Enterprise History & Synopsis
    Enterprise History & Synopsis
  • Enterprise Financial Statements
    Company Financial Statements
  • Financial Ratios
    Industry Market Share Breakdown
  • Industry Averages
    Industry Competitor Matrix
  • Competitive Landscape
    SWOT Analysis
  • Key Enterprise Personnel
    Products and Services
  • Subsidiaries & Ownership Structure
    Key Company Benchmarks

Why purchase access to Benchmarking Pro?

This profile on Glaxosmithkline Plc includes:

  • Company Overview
  • Company Revenue and Employee Data
  • Company Financial Statements
  • Industry Market Share Breakdown
  • Industry Competitor Matrix
  • SWOT Analysis
  • Products and Services
  • Key Company Benchmarks
  • Interconnected Competitor Profiles and Industry Reports
  • Full Access to Benchmarking Pro

The IBISWorld Benchmarking Pro solution enables you to:

  • Understand an enterprise’s competitive landscape and how they perform within a like-sized industry segment.
  • Benchmark companies against industry averages, segment averages and their competitors.
  • Identify real-world strengths, opportunities, weaknesses and threats for companies.
  • Target growth opportunities or spot red flags in a business growth strategy.
  • Toggle between company profiles and industry reports for a 360 degree view of a company's position.

IBISWorld provides profiles on thousands of leading companies around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends across all sectors of the economy. This company profile, along with the corresponding competitor and industry data provided, includes thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

Trusted by More Than 10,000 Clients Around the World

  • IBISWorld client - VISA
  • IBISWorld client - ADP
  • IBISWorld client - Deloitte
  • IBISWorld client - AMEX
  • IBISWorld client - Bank of Montreal